Seres Therapeutics, Inc.MCRBNASDAQ
Loading
P/FCF Ratio Over TimeExpanding
Percentile Rank100
Studio
Year-over-Year Change

Price to free cash flow ratio

Latest
152.39
↑ 1259% vs avg
Percentile
P100
Near historical high
Streak
4 yr
Consecutive growthExpanding
Average
-13.15
Historical baseline
PeriodValueYoY Change
2025152.39+17682.1%
2024-0.87+39.4%
2023-1.43+43.6%
2022-2.54+99.0%
2021-265.42-1179.0%
2020-20.75-723.1%
2019-2.52+11.3%
2018-2.84+44.4%
2017-5.11-129.1%
201617.59-